GenTrust’s CME Group CME Stock Holding History

GenTrust’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-16,047	Closed	-$1.9M	–	77
2016 Q4	$1.9M	Buy	+16,047	New	+$1.79M	0.38%	34

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

GenTrust's CME Position: Q1 2017 in Review

GenTrust sold out of CME Group (CME) in Q1 2017, closing a stake of 16,047 shares — an estimated $1.9M sold.

GenTrust first reported a position in CME in Q4 2016 and held it in 1 quarter. The position peaked at $1.9M in Q4 2016. 763 funds tracked by Wall St. Rank hold CME as of Q1 2017.

GenTrust reported no remaining CME Group position as of Q1 2017 after selling out during the quarter.
GenTrust sold 16,047 CME Group shares in Q1 2017, an estimated $1.9M.
GenTrust first reported a position in CME Group in Q4 2016 and held it in 1 quarter.
GenTrust's CME Group position peaked at $1.9M in Q4 2016.
763 funds tracked by Wall St. Rank held CME Group as of Q1 2017.

Based on GenTrust's 13F filing for Q1 2017, filed 15 May 2017.